RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Arulanandam, Bernard
One or more keywords matched the following items that are connected to Arulanandam, Bernard
Item TypeName
Academic Article Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ?fopC vaccine strain.
Academic Article A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.
Academic Article Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response.
Academic Article Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182.
Academic Article Antigen-Specific CD4+ T Cell-Derived Gamma Interferon Is Both Necessary and Sufficient for Clearing Chlamydia from the Small Intestine but Not the Large Intestine.
Academic Article The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.
Academic Article Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
Academic Article Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
Academic Article Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
Academic Article CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.
Concept CD4-Positive T-Lymphocytes
Search Criteria
  • CD4 Positive T Lymphocytes
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support